Correlation Between Karolinska Development and Clinical Laserthermia

Can any of the company-specific risk be diversified away by investing in both Karolinska Development and Clinical Laserthermia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karolinska Development and Clinical Laserthermia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Karolinska Development AB and Clinical Laserthermia Systems, you can compare the effects of market volatilities on Karolinska Development and Clinical Laserthermia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karolinska Development with a short position of Clinical Laserthermia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karolinska Development and Clinical Laserthermia.

Diversification Opportunities for Karolinska Development and Clinical Laserthermia

0.46

Correlation Coefficient

Karolinska Development  Clinical Laserthermia

Very weak diversification

The 3 months correlation between Karolinska and Clinical is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Karolinska Development AB and Clinical Laserthermia Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clinical Laserthermia and Karolinska Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karolinska Development AB are associated (or correlated) with Clinical Laserthermia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clinical Laserthermia has no effect on the direction of Karolinska Development i.e., Karolinska Development and Clinical Laserthermia go up and down completely randomly.

Pair Corralation between Karolinska Development and Clinical Laserthermia

Assuming the 90 days trading horizon Karolinska Development AB is expected to under-perform the Clinical Laserthermia. But the stock apears to be less risky and, when comparing its historical volatility, Karolinska Development AB is 1.79 times less risky than Clinical Laserthermia. The stock trades about -0.03 of its potential returns per unit of risk. The Clinical Laserthermia Systems is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  374.00  in Clinical Laserthermia Systems on November 20, 2024 and sell it today you would earn a total of  12.00  from holding Clinical Laserthermia Systems or generate 3.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.31%
Values	Daily Returns

Karolinska Development AB  vs.  Clinical Laserthermia Systems

Karolinska Development

Risk-Adjusted Performance

Very Weak

Over the last 90 days Karolinska Development AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Karolinska Development is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Clinical Laserthermia

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clinical Laserthermia Systems are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Clinical Laserthermia may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Pair Trading with Karolinska Development and Clinical Laserthermia

The main advantage of trading using opposite Karolinska Development and Clinical Laserthermia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karolinska Development position performs unexpectedly, Clinical Laserthermia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinical Laserthermia will offset losses from the drop in Clinical Laserthermia's long position.

The idea behind Karolinska Development AB and Clinical Laserthermia Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.